معرفی
Sara Alkner is an Associate Professor and Principal Investigator at Lund University Cancer Centre (LUCC), affiliated with Lund University's Faculty of Medicine. Her primary research focuses on breast cancer treatment, including radiotherapy optimization and clinical trials related to oncological interventions. She leads the T-REX trial, exploring tailored radiotherapy strategies for breast cancer patients.
Her research interests encompass breast cancer prognosis, therapeutic procedures, and the application of medical technologies like surface-guided radiotherapy. She actively contributes to Sustainable Development Goals related to health and well-being through her work.
Key achievements include three notable awards: the Bästa Vetenskapliga Ansökan (2022), recognition for her role in advancing surface-guided radiotherapy (2019), and the Guldpillret (2013). Her work is featured in high-impact journals like the New England Journal of Medicine and The Lancet Oncology.
Dr. Alkner supervises research projects and has organized numerous academic events, including LUCC retreats and seminars. She collaborates internationally and is a key figure in multidisciplinary oncology research.
